Oncura

Anastrozole (Arimidex): what to expect

BreastTaken continuously — no infusion cycle5 effects documented

A daily hormone-blocking pill for post-menopausal patients, taken for years. Hot flashes and joint aches are the common effects; the main long-term concern is gradual bone thinning, which your team monitors.

ORAL daily aromatase inhibitor, for years. NO infusion cycle. Hot flashes emerge over weeks; joint pain over 1-3 months; bone-density loss and fractures are CUMULATIVE over years. Vs tamoxifen: fewer clots and uterine effects, but more joint/bone effects.

Get help straight away — this is true on any regimen, on any day.

A temperature of 100.4°F (38°C) or higher during treatment can mean a serious infection while your blood counts are low. Call your team or go to the ER — do not wait it out.

Also urgent: trouble breathing or chest pain · swelling of the face, lips or throat · new confusion or fainting · shaking chills · not being able to keep fluids down.

This is standing guidance shown to everyone. Nothing on this page is based on anything about you, and nobody is monitoring you.

What is reported

This regimen is taken continuously, so effects are described in the terms their sources use rather than by cycle day.

Hot flashes

over the first weeks; ongoing

Sudden warmth, flushing, or sweating, developing over the first weeks of use.

reported by about 36% of people · from Anastrozole

Arthralgia

usually 1-3 months in, then plateaus

Joint aches and stiffness — a hallmark of aromatase inhibitors, usually developing over the first 1-3 months.

Call your team: Joint pain that stops you doing everyday tasks.

reported by about 15% of people · from Anastrozole

Bone density loss

cumulative over years

Gradual bone thinning that raises fracture risk over years. Your team monitors bone density and may add bone-protecting treatment.

reported by about 10% fractures (ATAC) of people; severe in 11% · from Anastrozole

Fatigue

Tiredness, developing over the first weeks and often persistent.

reported by about 19% of people · from Anastrozole

Mood changes

Some people notice low mood or depression over weeks to months.

reported by about 13% of people · from Anastrozole

Where this comes from

  1. S1. Anastrozole (Arimidex) FDA prescribing information, ATAC trial (n=3092 vs tamoxifen) (2024) — FDA label 020541s036

A window appears here only where a retrievable document ties it to a drug in this regimen. Where nothing could be found, the window was removed rather than estimated — so a missing time is an honest gap, not an oversight.

Track your own cycle in Oncura →

Free, no account, nothing leaves your device.